Re­volv­ing door be­tween in­dus­try and FDA con­tin­ues to spin

It’s well known that leav­ing the FDA for in­dus­try can bring a ma­jor salary bump, so it should come as no sur­prise that the num­ber of FDA em­ploy­ees mak­ing the leap in 2018 con­tin­ues to in­crease.

Biotech com­pa­ny Mod­er­na an­nounced Wednes­day that Welling­ton Sun, for­mer di­rec­tor of the Di­vi­sion of Vac­cines and Re­lat­ed Prod­uct Ap­pli­ca­tions at FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search, will be their new head of vac­cine strat­e­gy and reg­u­la­to­ry af­fairs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER